![]() |
市場調查報告書
商品編碼
2059064
2034年全球發酵乳製品替代品市場預測-按產品類型、技術、原料、應用和最終用戶分類的分析Cultured Dairy Alternatives Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Base Material, Application, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球發酵乳製品替代品市場規模將達到 348 億美元,並在預測期內以 10.3% 的複合年成長率成長,到 2034 年將達到 765 億美元。
發酵乳製品替代品是指利用細胞農業和精準培養技術生產的非動物性乳製品,其生產過程旨在複製傳統牛奶中的蛋白質。與依賴牲畜不同,這些產品透過基因工程改造微生物來生產酪蛋白、乳清蛋白和其他乳製品成分,然後將其與植物來源基質結合。這些產品的目標是在提供與傳統乳製品相同的口感、質地和功能的同時,避免乳糖攝入,並實現環境永續。其應用範圍包括牛奶、起司、優格和冰淇淋。發酵乳製品代表著一個快速發展的領域,它連結了生物技術和食品創新。
乳糖不耐症人群日益增多
消費者越來越傾向於選擇植物來源和發酵乳製品來取代傳統乳製品。人們對消化器官系統健康問題的日益關注推動了無乳糖產品的普及。年輕一代更容易接受乳製品替代品。食品公司正不斷創新發酵乳製品的配方,力求在口感和質地上與傳統乳製品媲美。預防醫學的發展趨勢也促進了功能性乳製品替代品的需求。
感官特性缺乏一致性
重現傳統乳製品的口感和質地仍然是一項挑戰。消費者常常覺得不同批次的乳製品口味不一致。質地問題降低了市場接受度。製造商需要投入高昂的成本來改善感官品質。儘管乳製品有益健康,但缺乏一致性阻礙了其更廣泛的普及。這一因素減緩了乳製品在競爭激烈的地區的市場滲透速度。
含有功能性益生菌的產品
消費者越來越傾向於選擇能夠促進腸道健康和增強免疫力的產品。添加益生菌可以提升產品的營養價值,並使產品脫穎而出。口味和包裝的創新也能提高消費者的興趣。價格親民、富含益生菌的產品能夠吸引大眾消費者。與健康品牌合作可以擴大產品覆蓋範圍。隨著預防性醫療保健日益受到重視,預計這一細分市場將快速成長。
核准過程中的監管障礙
人造乳製品通常需要符合嚴格的食品安全標準。標籤和功效聲明框架因地區而異。監管的不確定性會延緩產品上市和創新。高昂的合規成本是中小企業面臨的一大障礙。媒體對檢驗的效力聲明的負面報導會削弱消費者信心。這些監管壓力限制了市場的快速擴張。
新冠疫情對發酵乳製品替代品市場產生了複雜的影響。一方面,隨著消費者更加重視免疫力和消化健康,需求增加。疫情封鎖期間,線上銷售管道顯著成長。另一方面,供應鏈中斷影響了原料採購。經濟的不確定性導致部分地區奢侈品消費減少。人們對預防醫學的認知提高,也促使更多人選擇富含益生菌的食品。
在預測期內,微生物培養領域預計將佔據最大佔有率。
預計在預測期內,微生物培養產品將佔據最大的市場佔有率,因為它能提供口感和質地更佳的發酵乳製品替代品。培養技術可以提高營養價值,並有助於強化益生菌。製造商正在投資微生物技術,以複製傳統乳製品的特性。由於消費者對優格和Kefir的熟悉程度不斷提高,他們對發酵產品的接受度也不斷提高。在已開發市場,發酵替代品在零售市場正日益受到歡迎。口味和包裝方面的創新正在推動市場成長。
預計在預測期內,營養食品細分市場將呈現最高的複合年成長率。
在預測期內,由於消費者對功能性和強化乳製品替代品的需求不斷成長,營養食品領域預計將呈現最高的成長率。消費者正在將富含益生菌、維生素和礦物質的發酵產品納入日常飲食中。尤其年輕一代更傾向選擇強化健康食品。數位平台和健身宣傳活動正在大力宣傳營養益處。醫療保健專業人員也擴大推薦富含益生菌的飲食。膳食補充劑和強化零食的創新也進一步提升了它們的受歡迎程度。
在預測期內,由於消費者意識高以及植物來源產品日益普及,歐洲地區預計將佔據最大的市場佔有率。歐洲市場擁有完善的法規結構,為發酵乳製品的創新提供了支持。許多大型企業和研究機構的總部都設在該地區。消費者對永續性的關注度日益提高。在德國、法國和英國等國家,發酵乳製品替代品在零售市場正逐漸獲得認可。預防醫學和環保生活方式正在推動市場需求。歐洲將繼續成為全球整體銷售額的最大貢獻者。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於可支配收入的成長和健康意識的提高。發酵乳製品替代品在中國、印度和東南亞的都市區正迅速普及。電子商務平台正在協助富含益生菌的小眾產品的分銷。文明病的日益普遍推動了人們對均衡營養的需求。價格親民的發酵乳製品正受到廣大消費者的青睞。年輕一代正積極將機能性食品融入日常飲食中。亞太地區可望成為全球成長最快的地區。
According to Stratistics MRC, the Global Cultured Dairy Alternatives Market is accounted for $34.80 billion in 2026 and is expected to reach $76.50 billion by 2034 growing at a CAGR of 10.3% during the forecast period. Cultured dairy alternatives are non-animal dairy products produced using cellular agriculture or precision fermentation to replicate the proteins found in conventional milk. Instead of relying on livestock, microorganisms are engineered to produce casein, whey, or other dairy components, which are then combined with plant-based matrices. These products aim to deliver the same taste, texture, and functionality as traditional dairy while being lactose-free and environmentally sustainable. Applications include milk, cheese, yogurt, and ice cream. Cultured dairy represents a rapidly evolving segment bridging biotechnology and food innovation.
Lactose intolerance population growth
Consumers are increasingly seeking plant-based and cultured alternatives to traditional dairy products. Growing awareness of digestive health issues supports adoption of lactose-free options. Younger demographics are more open to experimenting with dairy alternatives. Food companies are innovating with cultured formulations to replicate taste and texture. Preventive health trends are boosting demand for functional dairy substitutes.
Limited sensory profile consistency
Replicating the exact taste and texture of traditional dairy remains challenging. Consumers often perceive variations in flavor across different batches. Texture issues reduce acceptance in mainstream markets. Manufacturers face high costs in improving sensory quality. Limited consistency restricts wider adoption despite health benefits. This factor slows down market penetration in competitive regions.
Functional probiotic-rich formulations
Consumers are increasingly seeking products that support gut health and immunity. Probiotic fortification enhances nutritional value and differentiates offerings. Innovation in flavors and packaging boosts consumer appeal. Affordable probiotic-rich options can attract mass-market buyers. Partnerships with wellness brands expand reach. This segment is expected to grow rapidly as preventive health becomes a priority.
Regulatory hurdles for approval
Cultured dairy alternatives often require compliance with strict food safety standards. Different regions have varying frameworks for labeling and claims. Regulatory uncertainty slows product launches and innovation. High compliance costs create barriers for smaller companies. Negative publicity around unverified claims can reduce consumer confidence. This regulatory pressure limits faster expansion of the market.
Covid-19 had a mixed impact on the cultured dairy alternatives market. On one hand, demand rose as consumers focused on immunity and digestive health. Online sales channels grew significantly during lockdowns. On the other hand, supply chain disruptions affected ingredient availability. Economic uncertainty limited premium purchases in some regions. Preventive health awareness increased adoption of probiotic-rich foods.
The microbial fermentation segment is expected to be the largest during the forecast period
The microbial fermentation segment is expected to account for the largest market share during the forecast period as it provides cultured dairy alternatives with improved taste and texture. Fermentation enhances nutritional value and supports probiotic fortification. Manufacturers are investing in microbial technologies to replicate traditional dairy characteristics. Consumer acceptance is higher for fermented products due to familiarity with yogurt and kefir. Retail penetration of fermented alternatives is strong in developed markets. Innovation in flavors and packaging supports growth.
The nutritional foods segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the nutritional foods segment is predicted to witness the highest growth rate due to rising demand for functional and fortified dairy alternatives. Consumers are adopting cultured products enriched with probiotics, vitamins, and minerals. Younger demographics are particularly inclined toward fortified wellness foods. Digital platforms and fitness campaigns promote nutritional benefits. Healthcare providers are increasingly recommending probiotic-rich diets. Innovation in supplements and fortified snacks supports adoption.
During the forecast period, the Europe region is expected to hold the largest market share owing to strong consumer awareness and established plant-based adoption. European markets have advanced regulatory frameworks supporting cultured dairy innovation. Leading companies and research institutions are headquartered in this region. Sustainability trends are well established among consumers. Retail penetration of cultured alternatives is strong in countries such as Germany, France, and the UK. Preventive health and eco-conscious lifestyles drive demand. Europe will remain the largest contributor to global revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising disposable incomes and growing health consciousness. Urban populations in China, India, and Southeast Asia are adopting cultured dairy alternatives rapidly. E-commerce platforms support distribution of niche probiotic-rich products. Lifestyle-related diseases are increasing, fueling demand for balanced nutrition. Affordable cultured options appeal to mass consumers. Younger demographics are embracing functional foods. Asia Pacific will be the fastest-growing region globally.
Key players in the market
Some of the key players in Cultured Dairy Alternatives Market include Perfect Day, Inc., Remilk Ltd., Moodify Ltd., Nestle S.A., Danone S.A., Unilever plc, General Mills, Inc., Glanbia plc, Lactalis Group, Fonterra Co-operative Group Ltd., Bel Group, Valio Ltd., DMK Group, TurtleTree Labs and Borealis Foods.
In November 2025, Remilk officially launched its "New Milk" line in Israel through a joint venture with Gad Dairies, the country's leading specialty dairy distributor. This collaborative initiative takes ownership of the entire value chain, combining Remilk's precision-fermented beta-lactoglobulin with Gad's extensive logistics network to reach cafes and retail shelves nationwide.
In October 2024, Borealis Foods expanded its U.S. distribution through Walmart with the launch of "Ramen Noodles by Chef Ramsay," a product line crafted in collaboration with MasterChef Gordon Ramsay. This strategic partnership utilizes the brand's mission-driven food technology to deliver high-protein, nutrient-dense meals to a mass-market audience, successfully selling over 2 million units on Amazon by the end of that year.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.